Literature DB >> 28878601

An Atypical Presentation of Retroperitoneal Fibrosis.

Wei Phin Tan1, Thomas Hwang1, Robert Medairos1, Dennis A Pessis1.   

Abstract

A 69-year-old man with a psoriatic arthritis treated with infliximab for 1 month presented to the urology clinic for lower urinary tract symptoms. He was found to have a new diagnosis of elevated creatinine. Computed tomography of the abdomen and pelvis revealed bilateral severe hydronephrosis with abnormal soft tissue thickening of the right renal pelvis and proximal ureter. Bilateral stents were placed after ureteroscopy demonstrated no abnormalities. A computed tomography-guided biopsy of the peri-ureteral lesions revealed fibroadipose tissue with sclerosis and extensive chronic inflammation consistent with retroperitoneal fibrosis. Infliximab was discontinued and the patient was started on corticosteroids. Follow-up magnetic resonance imaging of the abdomen and pelvis at 2 months revealed total resolution of soft tissue and inflammation along the proximal ureter bilaterally. Repeat imaging demonstrated no hydronephrosis after stents removal, and the patient's creatinine remains normal at 12 months follow-up.

Entities:  

Keywords:  Hydronephrosis; Idiopathic fibrosis; Infliximab; Mesenteric sclerosis; Retroperitoneal fibrosis

Year:  2017        PMID: 28878601      PMCID: PMC5582446          DOI: 10.1159/000447172

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  5 in total

1.  Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis.

Authors:  D Corradi; R Maestri; A Palmisano; S Bosio; P Greco; L Manenti; S Ferretti; R Cobelli; G Moroni; A P Dei Tos; C Buzio; A Vaglio
Journal:  Kidney Int       Date:  2007-07-11       Impact factor: 10.612

Review 2.  Retroperitoneal fibrosis.

Authors:  E S Amis
Journal:  AJR Am J Roentgenol       Date:  1991-08       Impact factor: 3.959

Review 3.  Idiopathic retroperitoneal fibrosis.

Authors:  H Lepor; P C Walsh
Journal:  J Urol       Date:  1979-07       Impact factor: 7.450

4.  Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.

Authors:  Maria Grazia Catanoso; Lucia Spaggiari; Luca Magnani; Nicolò Pipitone; Annibale Versari; Luigi Boiardi; Giulia Pazzola; Pierpaolo Pattacini; Carlo Salvarani
Journal:  Clin Exp Rheumatol       Date:  2012-10-17       Impact factor: 4.473

Review 5.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

  5 in total
  1 in total

1.  Incidence, prevalence and mortality of chronic periaortitis: a population-based study.

Authors:  Matthew J Koster; Umar Ghaffar; Stephanie Q Duong; Cynthia S Crowson; Michelle M Burke; Boyd R Viers; Aaron M Potretzke; Haraldur Bjarnason; Kenneth J Warrington
Journal:  Clin Exp Rheumatol       Date:  2022-02-01       Impact factor: 4.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.